Camphor Homeopathic granules, 8.0

Name: Camphor Homeopathic granules, 8.0
SKU: OTC10201063
Price: 8.28 USD
Availability: InStock

Be the first to review this product

Special Price $8.28 Regular Price $18.00

In stock

SKU

OTC10201063

165.6 Reward Points will be used to purchase this product

Category

Homeopathy

Laxatives

Scope of the drug

Neurology, psychiatry

Release form

Granules

Manufacturer country

Russia

Brand name

Homeopathic Pharmacy

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Details

Description

Active ingredients Ketoprofen

Country of originRussia

ManufacturerOZON, OOO

Release form Gel for external use 2.5%, 50 g in a tube.

Each tube, together with instructions for use, is placed in a cardboard box (pack).

Store in a dark place

Keep out of reach of children

Dosage form

Colorless, transparent or opalescent gel with a characteristic odor.

Structure

100 g of gel contains:

active substance: ketoprofen 2.5 g

excipients: carbomer 1.5 g, ethanol 95% 32.0 g, trolamine 2.9 g, lavender oil 0.1 g, water up to 100.0 g.

general description

NSAIDs for external use

Special conditions

Do not apply to damaged (incl. Open wounds) and inflamed skin!

Avoid contact with eyes (risk of irritation of the conjunctiva).

It is recommended to wash your hands thoroughly after using the drug.

Do not use as a hermetic bandage.

Do not use in conjunction with sealed clothing.

Prolonged use of topical agents can lead to sensitization or local irritation.

In order to avoid any manifestations of hypersensitivity or photosensitization, exposure to direct sunlight (including visiting a solarium) should be avoided during the treatment period and within two weeks after using the drug, and it is recommended to cover the treated areas with clothing.

Patients with severe renal, heart or hepatic insufficiency should be careful when using ketoprofen.

Discontinue use of the drug in case of any skin reaction, including reactions with the simultaneous application of sunscreen or other cosmetic products containing octocrylene organic sunscreen filter to the skin.

When using the drug in large quantities, it is possible, in very rare cases, the development of systemic side effects (hypersensitivity, bronchial asthma, disorders of the gastrointestinal tract, aggravation of the course of renal failure).

The risk of systemic side effects increases depending on the amount of gel applied, the area of the treated skin area, the condition of the skin, and the duration of treatment.

Avoid exposure of the treated areas to sunlight or UV rays, including tanning beds, during treatment and for two weeks after treatment.

Influence on the ability to drive vehicles and other mechanisms:

The drug does not affect the ability to drive a car or other mechanical means.

Drug interactions

With external use of ketoprofen in the form of a gel, it is possible to enhance the action of drugs that cause photosensitization.

Other interactions have not been established, however, patients taking coumarin-type anticoagulants are advised to regularly monitor the international normalized ratio (INR).

Pharmacodynamics

Provides local anti-inflammatory, anti-exudative and analgesic effects.

By inhibiting cyclooxygenase I and II, it inhibits the synthesis of prostaglandins.

It has anti-bradykinin activity, stabilizes lysosomal membranes and delays the release of enzymes that contribute to tissue destruction in chronic inflammation.

Ketoprofen, penetrating the skin, reaches the focus of inflammation, thus providing the possibility of local treatment of lesions (joints, tendons, ligaments and muscles) accompanied by pain.

With articular syndrome, it causes a decrease in joint pain in mowing and during movement, a decrease in morning stiffness and swelling of the joints.

Pharmokinetics

When applied externally, it penetrates into the focus of inflammation through the skin, the absorption of ketoprofen from the focus of inflammation into the systemic circulation occurs extremely slowly (the bioavailability of the gel is about 5%).

After application in a dose of 50-150 mg of ketoprofen, the concentration in blood plasma after 5-8 hours is 0.08-0.15 μg / ml.

Virtually no cumulates in the body.

It is excreted mainly through the kidneys in the form of glucuronide.

Indications

- Acute and chronic inflammatory diseases of the musculoskeletal system (articular syndrome with exacerbation of gout, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, osteoarthritis, osteochondrosis with radicular syndrome, sciatica, inflammatory lesions of the ligaments and tendons of the ileus, bursitis, lumbar arthritis)

- muscle pains of rheumatic and non-rheumatic origin

- post-traumatic inflammation of soft tissues and musculoskeletal system (injuries and ruptures of ligaments, bruises).

The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.

Contraindications

- Individual hypersensitivity to ketoprofen or other components of the drug, acetylsalicylic acid or other NSAIDs (a history of bronchospasm, urticaria or rhinitis caused by taking acetylsalicylic acid), tiaprofenic acid and fenofibrate

- complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose or paranasal sinuses and intolerance to acetylsalicylic acid and other NSAIDs (including a history)

- a history of increased sensitivity of the skin to the effects of solar radiation (photosensitivity)

- a history of skin allergies to sunscreens or perfumes

- exposure to the sun on the treated areas, including the solarium, during the course of the drug use and 2 weeks after

- weeping dermatoses, eczema, infected abrasions, wounds (at the site of application of the gel)

- children under 12 years of age (efficacy and safety have not been studied)

- pregnancy (III trimester) and the period of breastfeeding.

Carefully:

Hepatic porphyria (exacerbation), erosive and ulcerative lesions of the gastrointestinal tract, severe liver and kidney dysfunction, chronic heart failure, bronchial asthma, old age, pregnancy (I and II trimester).

Pregnancy and lactation:

The use of the drug during breastfeeding is not recommended.

Overdose

Extremely low systemic absorption of the active components of the drug when applied externally makes an overdose almost impossible.

In case of accidental ingestion of large amounts of the drug (more than 20 g), systemic adverse reactions characteristic of NSAIDs may occur.

It is necessary to wash the stomach, take activated charcoal.

Treatment is symptomatic.

Side effects

Possible side effects are given in descending order of occurrence: very often (> 10%), often (> 1%, < 10%), infrequently (> 0.1%, < 1%), rarely (> 0.01%, < 0.1%), very rarely (< 0.01%).

On the part of the skin: infrequently - erythema, itching, eczema

rarely - photosensitivity, bullous dermatitis, urticaria

very rarely - contact dermatitis, angioedema.

Name ENG

KETOPROFEN

Clinical and pharmacological group

NSAIDs for external use

ATX code

Ketoprofen

Dosage

2.5% x 50g

Structure

ketoprofen

Indications

Individual hypersensitivity to ketoprofen or other components of the drug, acetylsalicylic acid or other NSAIDs (a history of bronchospasm, urticaria or rhinitis caused by taking acetylsalicylic acid)

tiaprofenic acid and fenofibrate

complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose or paranasal sinuses and intolerance to acetylsalicylic acid and other NSAIDs (including a history)

a history of increased sensitivity of the skin to the effects of solar radiation (photosensitivity)

a history of skin allergies to sunscreens or perfumes

exposure to the sun on the treated areas, including a solarium during the course of the drug and 2 weeks after.

weeping dermatoses, eczema, infected abrasions, wounds (at the site of application of the gel)

children under 12 years of age (efficacy and safety have not been studied)

pregnancy (III trimester) and breastfeeding period.

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

INN / Active ingredient

ketoprofen

Contraindications

tiaprofenic acid and fenofibrate

complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose or paranasal sinuses and intolerance to acetylsalicylic acid and other NSAIDs (including a history)

a history of increased sensitivity of the skin to the effects of solar radiation (photosensitivity)

- a history of skin allergies to sunscreens or perfumes

exposure to the sun on the treated areas, including a solarium during the course of the drug and 2 weeks after.

weeping dermatoses, eczema, infected abrasions, wounds (at the site of application of the gel)

children under 12 years of age (efficacy and safety have not been studied)

pregnancy (III trimester) and breastfeeding period.

Contraindicated for use in the third trimester of pregnancy.

In the I and II trimesters of pregnancy, the use of ketoprofen is possible in cases where the potential benefit to the mother outweighs the potential risk to the fetus.

If necessary, the use of ketoprofen during lactation is recommended to stop breastfeeding.

Specifications

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review

If you have PayPal and you are ready to earn in our team - contact us: [email protected]